project id: TCGA-CHOL; case submitter id: TCGA-W5-AA2K; selected normal wgs: true; source center: 23; state: released; analyte type: DNA; analyte type id: D; spectrophotometer method: PicoGreen; age at index: 75; days to birth: -27718; days to death: 833; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1933; year of death: 2010; age at diagnosis: 27718; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C22.1; last known disease status: not reported; morphology: 8160/3; primary diagnosis: Cholangiocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Intrahepatic bile duct; synchronous malignancy: No; tissue or organ of origin: Intrahepatic bile duct; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; days to collection: 2095; initial weight: 210.0; sample id: ed74a1ff-407c-4110-9d7f-0e85e4c4c2c2; sample submitter id: TCGA-W5-AA2K-01A; portion id: e591d5ec-6caa-4531-9be5-2f27cdce1eb5; portion submitter id: TCGA-W5-AA2K-01A-11; slide id: 8d5b728e-7c86-46ba-8620-4579225a2e99; slide submitter id: TCGA-W5-AA2K-01A-01-TSA; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 65.0; section location: TOP;